Rare diseases do not receive enough attention for the impact they have on patients and their families. This is what AlphaRose’s founder and CEO Casey McPherson learned after his daughter was diagnosed with a rare condition. In a conversation with host Ari Berman, McPherson shares how he switched from music to founding his own pharmaceutical company, what technologies AlphaRose is developing, and how his company is creating environments that allow innovation and iteration. He also shares his t...
All content for Trends from the Trenches is the property of Bio-IT World and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Rare diseases do not receive enough attention for the impact they have on patients and their families. This is what AlphaRose’s founder and CEO Casey McPherson learned after his daughter was diagnosed with a rare condition. In a conversation with host Ari Berman, McPherson shares how he switched from music to founding his own pharmaceutical company, what technologies AlphaRose is developing, and how his company is creating environments that allow innovation and iteration. He also shares his t...
Episode: 35 - A Farewell to Stan Gloss: Founding BioTeam, Words of Wisdom, and More
Trends from the Trenches
28 minutes
5 months ago
Episode: 35 - A Farewell to Stan Gloss: Founding BioTeam, Words of Wisdom, and More
In this special transition episode of Trends from the Trenches, Ari Berman, CEO of BioTeam, takes the mic as the new host of the Trends from the Trenches podcast and speaks with founding host Stan Gloss, co-founder of BioTeam. During their conversation, they cover Stan’s journey as an entrepreneur, including the valuable lessons learned along the way, words of wisdom for people on similar paths, and what he is most proud of during his time at the company. Stan also discusses the impact dyslex...
Trends from the Trenches
Rare diseases do not receive enough attention for the impact they have on patients and their families. This is what AlphaRose’s founder and CEO Casey McPherson learned after his daughter was diagnosed with a rare condition. In a conversation with host Ari Berman, McPherson shares how he switched from music to founding his own pharmaceutical company, what technologies AlphaRose is developing, and how his company is creating environments that allow innovation and iteration. He also shares his t...
